ITC Board Approves Audited FY26 Results, Recommends ₹8 Dividend; AGM on July 23
ITC Limited's Board approved audited FY26 results, recommending a final dividend of ₹8 per share, totaling ₹14.50 for the year. The AGM is scheduled for July 23, 2026, with a record date of May 27, 2026. Mr. Hemant Bhargava's re-appointment as Director was also recommended.
The announcement includes the declaration of financial results and a dividend, which are material to investors. The re-appointment of a director is also a significant corporate governance event.
The company reported its annual financial results, recommended a final dividend, and scheduled its AGM, all of which are routine but positive corporate actions. The dividend recommendation is a direct benefit to shareholders.
ITC Limited announced its audited financial results for the quarter and twelve months ended March 31, 2026. The Board of Directors approved the standalone and consolidated financial results, including the audited Balance Sheet and Statement of Cash Flows. The company reported a recommended final dividend of ₹8 per Ordinary Share of ₹1 each for the financial year ended March 31, 2026. This, combined with the interim dividend of ₹6.50 per Ordinary Share, brings the total dividend for the financial year to ₹14.50 per Ordinary Share. The Record Date for this final dividend has been fixed as May 27, 2026, and the payment is scheduled between July 24, 2026, and July 29, 2026. The company also announced that its 115th Annual General Meeting (AGM) has been convened for Thursday, July 23, 2026. Additionally, the Board recommended the re-appointment of Mr. Hemant Bhargava as a Director and Independent Director for a period of five years, effective December 20, 2026, subject to member approval.
The financial results for the twelve months ended March 31, 2026, showed consolidated revenue from operations of ₹99,514.69 crore, with a profit before tax of ₹28,033.39 crore. Standalone revenue from operations was ₹90,713.20 crore, with a profit before tax of ₹26,767.60 crore. The company noted the amalgamation of its wholly owned subsidiaries, Sresta Natural Bioproducts Private Limited and Wimco Limited, with ITC, which has been given effect to from their respective appointed dates.
The auditors, Messrs. S R B C & CO LLP, Chartered Accountants, have issued their reports with an unmodified opinion on the financial results.
What to do with a filing like this
ITC Limited filed this with the NSE as a statutory disclosure, categorised under annual results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by ITC Limited. Read the original for the full detail.